Milestone Scientific Inc. (MLSS) P/E Ratio History
Historical price-to-earnings valuation from 2013 to 2014
Loading P/E history...
MLSS Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Milestone Scientific Inc. (MLSS) trades at a price-to-earnings ratio of -7.9x, with a stock price of $0.47 and trailing twelve-month earnings per share of $-0.09.
The current P/E is 105% below its 5-year average of 164.5x. Over the past five years, MLSS's P/E has ranged from a low of 19.6x to a high of 710.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, MLSS trades at a 136% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, MLSS trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MLSS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MLSS P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $8B | 21.6Lowest | 6.84 | +7% | |
| $4B | 86.7 | 58.08 | +104%Best | |
| $12B | 29.8 | - | +1% | |
| $4B | 29.3 | - | +5% | |
| $100B | 21.6 | - | +31% | |
| $113B | 35.0 | 2.36 | +8% | |
| $56B | 26.3 | 1.59Best | -1% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MLSS Historical P/E Data (2013–2014)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2014 Q3 | $1.85 | $0.04 | 43.9x | -73% | |
| FY2014 Q2 | Mon Jun 30 2014 00:00:00 GM | $1.90 | $0.07 | 27.5x | -83% |
| FY2014 Q1 | Mon Mar 31 2014 00:00:00 GM | $1.60 | $0.08 | 19.6x | -88% |
| FY2013 Q4 | $1.70 | $0.08 | 20.8x | -87% | |
| FY2013 Q3 | Mon Sep 30 2013 00:00:00 GM | $1.35 | $0.00 | 710.5x | +332% |
Average P/E for displayed period: 164.5x
See MLSS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MLSS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MLSS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMLSS — Frequently Asked Questions
Quick answers to the most common questions about buying MLSS stock.
Is MLSS stock overvalued or undervalued?
MLSS trades at -7.9x P/E, below its 5-year average of 164.5x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does MLSS's valuation compare to peers?
Milestone Scientific Inc. P/E of -7.9x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is MLSS's PEG ratio?
MLSS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2013-2014.